1
|
Shen CB, Qian X, Yu RX, Ji XL, Shi YJ, Gao J, Li CX, Li KK, Fei WM, Shen X, Wang ZY, Han Y, Ning XL, Ko R, Hsu YH, Yin XY, Li GW, Cui Y. Skin diseases in the Da Qing Diabetes Study: a cross-sectional study. Chin Med J (Engl) 2021; 134:1191-1198. [PMID: 34018997 PMCID: PMC8143734 DOI: 10.1097/cm9.0000000000001453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Indexed: 12/05/2022] Open
Abstract
BACKGROUND The prevalence of skin diseases and diabetes mellitus (DM) are prominent around the world. The current scope of knowledge regarding the prevalence of skin diseases and comorbidities with type 2 DM (T2DM) is limited, leading to limited recognition of the correlations between skin diseases and T2DM. METHODS We collected 383 subjects from the Da Qing Diabetes Study during the period from July 9th to September 1st, 2016. The subjects were categorized into three groups: Normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM. The prevalence and clinical characteristics of skin diseases were recorded and investigated. RESULTS In this cross-sectional study, 383 individuals with ages ranging from 53 to 89-year-old were recruited. The overall prevalence of skin diseases was 93.5%, and 75.7% of individuals had two or more kinds of skin diseases. Additionally, there were 47 kinds of comorbid skin diseases in patients with T2DM, of which eight kinds of skin diseases had a prevalence >10%. The prevalence of skin diseases in NGT, IGT, and T2DM groups were 93.3%, 91.5%, and 96.6%, respectively; stratified analysis by categories showed a statistically significant difference in "disturbances of pigmentation" and "neurological and psychogenic dermatoses". The duration of T2DM also significantly associated with the prevalence of "disturbances of pigmentation" and "neurological and psychogenic dermatoses". Subsequently, the prevalence of "disturbances of pigmentation" was higher in males than females in NGT (P < 0.01) and T2DM (P < 0.01) groups. In addition, the difference in the prevalence of "disturbances of pigmentation" was also significant in NGT and T2DM groups (P < 0.01). CONCLUSIONS There was a high prevalence of skin diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study, increased awareness and intervention measures should be implemented.
Collapse
Affiliation(s)
- Chang-Bing Shen
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China
- Shenzhen Key Laboratory for Translational Medicine of Dermatology, Shenzhen Peking University – The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong 518036, China
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School, Boston, MA 02131, USA
| | - Xin Qian
- Center of Endocrinology and Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
| | - Rui-Xing Yu
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
| | - Xue-Lei Ji
- Department of Endocrinology and Metabolism, Second People's Hospital of Wuhu, Wuhu, Anhui 241000, China
| | - Yin-Juan Shi
- Department of Dermatology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
| | - Jing Gao
- Department of Dermatology, Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui 230601, China
| | - Cheng-Xu Li
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Ke-Ke Li
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Wen-Min Fei
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Xue Shen
- Department of Dermatology, Chengdu Second People's Hospital, Chengdu, Sichuan 610017, China
| | - Zi-Yi Wang
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Yang Han
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Xiao-Li Ning
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Randy Ko
- The University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
| | - Yi-Hsiang Hsu
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School, Boston, MA 02131, USA
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
| | - Xian-Yong Yin
- Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI 48109, USA
| | - Guang-Wei Li
- Center of Endocrinology and Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
- Department of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Yong Cui
- Department of Dermatology, China-Japan Friendship Hospital, Beijing 100029, China
- Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China
- Graduate School, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China
| |
Collapse
|
2
|
Fumarola S, Allaway R, Callaghan R, Collier M, Downie F, Geraghty J, Kiernan S, Spratt F, Bianchi J, Bethell E, Downe A, Griffin J, Hughes M, King B, LeBlanc K, Savine L, Stubbs N, Voegeli D. Overlooked and underestimated: medical adhesive-related skin injuries. J Wound Care 2020; 29:S1-S24. [DOI: 10.12968/jowc.2020.29.sup3c.s1] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Sian Fumarola
- Senior Clinical Nurse Specialist, Tissue Viability and Continence, University Hospitals of North Midlands NHS Trust, UK
| | - Rachel Allaway
- Tissue Viability Clinical Nurse Specialist, Great Ormond Street Hospital for Children NHS Foundation Trust, UK
| | - Rosie Callaghan
- Tissue Viability Lead, Worcestershire Health and Care NHS Trust, UK
| | - Mark Collier
- Nurse Consultant and Associate Lecturer, Tissue Viability, UK
| | - Fiona Downie
- Formerly Nurse Consultant, Tissue Viability, Royal Papworth Hospital NHS Foundation Trust, UK
| | - Jemell Geraghty
- Nurse Consultant, Tissue Viability, Camden Health Improvement Practice; Clinical Nurse Specialist, HCA Healthcare (Princess Grace); Visiting Clinical Teacher King's College Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, UK
| | - Sarah Kiernan
- Consultant Nurse, Tissue Viability, Forest Primary Care Centre, London, UK
| | - Fran Spratt
- Lead Nurse Tissue Viability, University Hospital Southampton NHS Foundation Trust, UK
| | - Janice Bianchi
- Independent Tissue Viability Nurse; Dermatology Educator and Honorary Lecturer, Glasgow University, UK
| | - Elaine Bethell
- Lead Nurse, Tissue Viability, Royal Orthopaedic Hospital, Birmingham, UK
| | - Annette Downe
- Epidermolysis Bullosa Clinical Nurse Specialist, St Thomas' Hospital, London, UK
| | - Jackie Griffin
- Tissue Viability Clinical Nurse Specialist, NHS Wales, UK
| | - Maria Hughes
- Independent Tissue Viability Consultant and Queens Nurse, UK
| | - Brenda King
- Nurse Consultant, Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - Kimberly LeBlanc
- Chair, Wound Ostomy Continence Institute and Association of Nurses Specialized in Wound Ostomy Continence, Canada
| | - Louise Savine
- Tissue Viability Lead Nurse, Imperial College Healthcare NHS Trust, London, UK
| | - Nikki Stubbs
- Clinical Project Lead for Integrated Wound Clinics, Leeds Community Healthcare NHS Trust, Leeds, UK
| | - David Voegeli
- Visiting Professor, Faculty of Health and Wellbeing, University of Winchester
| |
Collapse
|